
| Audit Committee Charter (PDF) | Compensation Committee Charter (PDF) | Nominating Committee Charter (PDF) | |||||
| Download Adobe Acrobat Reader |
|||||||
| Audit Committee | Compensation Committee | Nominating & Governance Committee | |
| Jean-Pierre Sommadossi, Ph.D. Founder, Chief Executive Officer and Chairman of the Board of Idenix |
|||
| Charles W. Cramb Executive Vice President, Finance and Technology and Chief Financial Officer, Avon Products, Inc. |
|||
| Wayne T. Hockmeyer, Ph.D. Chairman of the Board of Directors of MedImmune, Inc. |
|||
| Thomas R. Hodgson* Former President and Chief Operating Officer of Abbott Laboratories |
|||
| Tamar Howson Partner JSB-Partners |
|||
| Robert Pelzer President and Chief Executive Officer, Novartis Corporation |
|||
| Denise Pollard-Knight, Ph.D. Head of Nomura Phase4 Ventures | |||
| Stephen Projan, Ph.D. Vice President, Global Head of Infectious Diseases, Novartis Institute for Biomedical Research |
|||
| Anthony Rosenberg Global Head of Business Development and Licensing Novartis Pharma AG |
|||
* Lead Director | |||